The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicity and quality of life data from SCOT: An international phase III randomized (1:1) noninferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy.
 
Timothy Iveson
Honoraria - Amgen; Celgene; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Celgene; Sanofi
Travel, Accommodations, Expenses - Amgen; Celgene
 
Rachel Kerr
No Relationships to Disclose
 
Mark P. Saunders
No Relationships to Disclose
 
Ashita Marie Waterston
No Relationships to Disclose
 
Niels Henrik Hollander
No Relationships to Disclose
 
Louise C. Medley
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Charles Wilson
No Relationships to Disclose
 
Richard Ellis
No Relationships to Disclose
 
Sharadah Essapen
No Relationships to Disclose
 
Andrew Mark Haydon
No Relationships to Disclose
 
Amandeep Singh Dhadda
No Relationships to Disclose
 
Robert Hughes
No Relationships to Disclose
 
Stephen Falk
Consulting or Advisory Role - Amgen; Celgene; Merck Serono
Research Funding - Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Celgene
 
Sherif Abdel-Raouf
No Relationships to Disclose
 
Bengt Glimelius
No Relationships to Disclose
 
Karen Allan
No Relationships to Disclose
 
Winnie Barlow
No Relationships to Disclose
 
Andrew Briggs
No Relationships to Disclose
 
James Paul
No Relationships to Disclose